Literature DB >> 10896681

Lipoprotein lipase-mediated selective uptake from low density lipoprotein requires cell surface proteoglycans and is independent of scavenger receptor class B type 1.

T Seo1, M Al-Haideri, E Treskova, T S Worgall, Y Kako, I J Goldberg, R J Deckelbaum.   

Abstract

Lipoprotein lipase (LpL) hydrolyzes chylomicron and very low density lipoprotein triglycerides to provide fatty acids to tissues. Aside from its lipolytic activity, LpL promotes lipoprotein uptake by increasing the association of these particles with cell surfaces allowing for the internalization by receptors and proteoglycans. Recent studies also indicate that LpL stimulates selective uptake of lipids from high density lipoprotein (HDL) and very low density lipoprotein. To study whether LpL can mediate selective uptake of lipids from low density lipoprotein (LDL), LpL was incubated with LDL receptor negative fibroblasts, and the uptake of LDL protein, labeled with (125)I, and cholesteryl esters traced with [(3)H]cholesteryl oleoyl ether, was compared. LpL mediated greater uptake of [(3)H]cholesteryl oleoyl ether than (125)I-LDL protein, a result that indicated selective lipid uptake. Lipid enrichment of cells was confirmed by measuring cellular cholesterol mass. LpL-mediated LDL selective uptake was not affected by the LpL inhibitor tetrahydrolipstatin but was nearly abolished by heparin, monoclonal anti-LpL antibodies, or chlorate treatment of cells and was not found using proteoglycan-deficient Chinese hamster ovary cells. Selective uptake from HDL, but not LDL, was 2-3-fold greater in scavenger receptor class B type I overexpressing cells (SR-BI cells) than compared control cells. LpL, however, induced similar increases in selective uptake from LDL and HDL in either control or SR-BI cells, indicative of the SR-BI-independent pathway. This was further supported by ability of LpL to promote selective uptake from LDL in human embryonal kidney 293 cells, cells that do not express SR-BI. In Chinese hamster ovary cell lines that overexpress LpL, we also found that selective uptake from LDL was induced by both endogenous and exogenous LpL. Transgenic mice that overexpress human LpL via a muscle creatine kinase promoter had more LDL selective uptake in muscle than did wild type mice. In summary LpL stimulates selective uptake of cholesteryl esters from LDL via pathways that are distinct from SR-BI. Moreover this process also occurs in vivo in tissues where abundant LpL is present.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896681     DOI: 10.1074/jbc.M910327199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.

Authors:  Werner J Geldenhuys; Li Lin; Altaf S Darvesh; Prabodh Sadana
Journal:  Drug Discov Today       Date:  2016-10-19       Impact factor: 7.851

2.  Saturated fat-rich diet enhances selective uptake of LDL cholesteryl esters in the arterial wall.

Authors:  Toru Seo; Kemin Qi; Chuchun Chang; Ying Liu; Tilla S Worgall; Rajasekhar Ramakrishnan; Richard J Deckelbaum
Journal:  J Clin Invest       Date:  2005-07-21       Impact factor: 14.808

Review 3.  MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis.

Authors:  Andreas Schober; Maliheh Nazari-Jahantigh; Christian Weber
Journal:  Nat Rev Cardiol       Date:  2015-04-07       Impact factor: 32.419

4.  VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids.

Authors:  Maxwell A Ruby; Benjamin Goldenson; Gabriela Orasanu; Thomas P Johnston; Jorge Plutzky; Ronald M Krauss
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

5.  S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.

Authors:  Maite Martínez-Uña; Marta Varela-Rey; Daniela Mestre; Larraitz Fernández-Ares; Olatz Fresnedo; David Fernandez-Ramos; Virginia Gutiérrez-de Juan; Idoia Martin-Guerrero; Africa García-Orad; Zigmund Luka; Conrad Wagner; Shelly C Lu; Carmelo García-Monzón; Richard H Finnell; Igor Aurrekoetxea; Xabier Buqué; M Luz Martínez-Chantar; José M Mato; Patricia Aspichueta
Journal:  J Hepatol       Date:  2014-10-18       Impact factor: 25.083

Review 6.  Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.

Authors:  James W Yockman; Andrew Kastenmeier; Harold M Erickson; Jonathan G Brumbach; Matthew G Whitten; Aida Albanil; Dean Y Li; Sung Wan Kim; David A Bull
Journal:  J Control Release       Date:  2008-07-06       Impact factor: 9.776

7.  Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice.

Authors:  Ni-Huiping Son; Tae-Sik Park; Haruyo Yamashita; Masayoshi Yokoyama; Lesley A Huggins; Kazue Okajima; Shunichi Homma; Matthias J Szabolcs; Li-Shin Huang; Ira J Goldberg
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

Review 8.  Women and heart disease--physiologic regulation of gene delivery and expression: bioreducible polymers and ischemia-inducible gene therapies for the treatment of ischemic heart disease.

Authors:  James W Yockman; Sung Wan Kim; David A Bull
Journal:  Adv Drug Deliv Rev       Date:  2009-05-05       Impact factor: 15.470

Review 9.  n-3 Fatty acids and cardiovascular disease: actions and molecular mechanisms.

Authors:  C Torrejon; U J Jung; R J Deckelbaum
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2007-12-03       Impact factor: 4.006

10.  Genetic variants at the PDZ-interacting domain of the scavenger receptor class B type I interact with diet to influence the risk of metabolic syndrome in obese men and women.

Authors:  Mireia Junyent; Donna K Arnett; Michael Y Tsai; Edmond K Kabagambe; Robert J Straka; Michael Province; Ping An; Chao-Qiang Lai; Laurence D Parnell; Jian Shen; Yu-Chi Lee; Ingrid Borecki; Jose M Ordovás
Journal:  J Nutr       Date:  2009-03-25       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.